DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Gordon LI, Molina A, Witzig T. et al.
Durable responses after ibritumomab tiuxetan radioimmunotherapy for CD20+ B-cell lymphoma: long-term follow-up of a phase 1/2 study.
Blood 2004; 103: 4429-4431
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.